Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Spunky Beaver who wrote (2557)	6/9/1998 4:12:00 PM
From: Rubber Man	Respond to of 5736

Here's a brief summary of facts <g> : 60% of 4M babies born every year have some level of jaundice. That's 2.4M. (source: spectrx.com Average cost of test - $9 (I looked around, perhaps I'm underestimating) Suppose every infant that is suspected undergoes two tests before being cleared/diagnosed with hyperbilirubinemia. That's 2.4M x $9 x 2 = $43.2M IMO, in order for CCSI's device to be accepted it must be price competitive or better. If they can sell the device so it achieves acceptable cost savings within 3-5 years, the most they'll rake in is $216M worth ($43.2 x 5), unless we have another anomally in births. There are already devices like CCSI's. If CCSI could penetrate some 25% of the market within the next several years, that's $54M. While it's not the $2.5M Asensio mentioned, but it's far off from any figures I've heard from the company.

To: Spunky Beaver who wrote (2557)	6/9/1998 4:34:00 PM
From: Ron Harvey	Read Replies (2) \| Respond to of 5736

<<The only thing that will turn this stock around now that Asensio has found it is REVENUES. Until that happens, it will continue to fluctuate wildly as it slowly trends down.>> Nahh. If (when) the excitement of the story reasserts itself, CCSI will move north. Developmental companies like this (which, by definition, aren't going to have revenues) are basically event driven. The stock price of a company like this (and many hundreds of similar ones) is related to the glow of future prospects. When the glow is dimmed, the price droops; when the glow brightens, the price perks up. Moreover, I think the bears have pretty much used up their communication ammunition. All they can do now is reiterate what everyone already knows they've said, while a bullish case from this apparently meek company (re PR anyway) is still open to a host of positive possibilities.